乳がんにおける新しい細胞死メカニズムにおける進歩:フェロプトーシス,クプロプトーシス,ディスルフィドプトーシス,およびパイロプトーシスに関する交差点の視点
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
PubMedで要約を見る
まとめ
この要約は機械生成です。新しいプログラム細胞死 (PCD) 経路であるフェロプトーシスとピロプトーシスは 乳がんの進行と薬剤耐性を理解する鍵です これらのPCDメカニズムをターゲットにすることで 治療結果を改善する新しい精密医療戦略が生まれます
科学分野
- 腫瘍学
- 分子生物学
- 免疫学
背景
- 分子分類は乳がん治療を 精密医療へと進めています
- 薬剤耐性と腫瘍の異質性は,重要な臨床的課題である.
- 新しいプログラム細胞死 (PCD) 経路は 乳がんに重大な影響を及ぼします
研究 の 目的
- 乳がんにおけるフェロプトーシス,クプロプトーシス,ディスルフィドプトーシス,およびパイロプトーシスのメカニズム的基礎を体系的に検討する.
- 乳がんの病原性におけるこれらのPCD経路の分子調節ネットワークを調査する.
- 乳がん治療における現在の標的型介入とその臨床的翻訳の可能性を評価する.
主な方法
- 乳がんにおけるプログラム細胞死メカニズムの体系的な文献レビュー.
- PCD経路に関与する分子調節ネットワークの分析
- 標的治療戦略と臨床試験データを評価する.
主要な成果
- フェロプトーシス,クプロプトーシス,ディスルフィドプトーシス,そしてパイロプトーシスは乳がんの重要な調節因子として特定されています.
- これらのPCD経路は腫瘍の進行,治療応答,免疫微環境の改造に影響します.
- これらの経路を理解することで 薬剤耐性や異質性を克服する 洞察が得られます
結論
- 新しいPCD経路は,革新的な乳がん治療の有望なターゲットです.
- PCDメカニズムをターゲットにすることで,治療反応を高め,耐性を克服することができます.
- このレビューは,新しい精度ベースの乳がん治療の開発の枠組みを提供します.
自動的に一致したビデオです Contact us もしそれらが関連していない場合
自動的に一致したビデオです Contact us もしそれらが関連していない場合
関連する概念動画
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...